[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 35.175.212.130. Please contact the publisher to request reinstatement.
Article
March 1975

Ultraviolet Light Therapy for Psoriasis-Reply

Arch Dermatol. 1975;111(3):397. doi:10.1001/archderm.1975.01630150117024

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.

Abstract

To the Editor.—  I want to thank Drs. Tanenbaum, Pathak, and Parrish for their comments. There are, however, certain statements with which I take issue. In the first place, the definition of minimal erythemal dose (MED) refers to erythemogenic irradiation, not to the UVA spectrum. Since determination of MED is a biologic event, it is best measured by the erythema response to irradiation that simulates the natural environment—a combination of UVA and UVB in this instance. In our study, we utilized a constant dose that was shown to be twice the normal MED in our laboratory, with the use of an instrument that has been shown to emit ultraviolet (UV) radiation in a continuous spectrum resembling midday summer sunlight (J Invest Dermatol 53:192,1969). The authors of the letter refer to "MedB"—we never measure MED to a narrow band, only to a broad band encompassing UVA and UVB.It is necessary

First Page Preview View Large
First page PDF preview
First page PDF preview
×